Terms ending in 2040
Every in-force patent on Element Biosciences, Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,053,540 | High Performance Fluorescence Imaging Module for Genomic Testing Assay In force · Medium confidence | Element Biosciences, Inc. | In force | Medium confidence | |
| US 11,060,138 | Nucleic Acid Sequencing Systems In force · High confidence | Element Biosciences, Inc. | In force | High confidence | |
| US 11,339,433 | Nucleic Acid Sequencing Systems In force · Low confidence | Element Biosciences, Inc. | In force | Low confidence | |
| US 11,408,032 | Tube Lens Design for Improved Depth-Of-Field In force · High confidence | Element Biosciences, Inc. | In force | High confidence | |
| US 11,287,422 | Multivalent Binding Composition for Nucleic Acid Analysis In force · Low confidence | Element Biosciences, Inc. | In force | Low confidence | |
| US 12,241,891 | Multivalent Binding Composition for Nucleic Acid Analysis In force · Low confidence | Element Biosciences, Inc. | In force | Low confidence | |
| US 12,723,245 | Methods and Compositions for Phased Sequencing In force · High confidence | Element Biosciences, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.